Tweenvest Stocks

Modus Therapeutics Holding AB (publ) (OM: MODTX)

Health Care · Biotechnology · SE

Skr0.18

-52.45% today · -58.4% 1Y

Modus Therapeutics Holding AB (publ) (OM: MODTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.76M and employs 2 people.

Over the last twelve months the share price has lost 58.4%, trading between 0.16 and 0.60.

Tweenvest scores Modus Therapeutics Holding AB (publ) across four factors: quality 35/100, value 19/100. Its strongest factor is quality.

MODTX price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$2.76M
Revenue (TTM)
—
P/E
—
EPS
-0.16
Dividend yield
—
Beta (5Y)
0.37
52-week high
Skr0.60
52-week low
Skr0.16
Avg volume (3M)
—
Shares outstanding
148.70M
Employees
2
Next earnings
—

About Modus Therapeutics Holding AB (publ)

Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.

ISIN
SE0015987904
Founded
2011
Listed since
Jul 22, 2021
Exchange
OMX Nordic Exchange Stockholm
Currency
SEK
CompanyMarket capPriceDay
Aptevo Therapeutics Inc.NasdaqCM: APVO$2.92M$1.62-9.50%
Mustang Bio, Inc.NasdaqCM: MBIO$2.85M$0.38-5.92%
BSF Enterprise PlcLSE: BSFA$2.82M£0.01+0.00%
HCW Biologics Inc.NasdaqCM: HCWB$2.77M$1.24-22.50%
Vaccinex, Inc.OTCPK: VCNX$2.69M$1.01-11.81%
Bioxytran, Inc.OTCPK: BIXT$2.67M$0.02+1.75%
Spermosens AB (publ)NGM: SPERM$2.67MSkr——
VivoSim Labs, Inc.NasdaqCM: VIVS$2.60M$0.16-12.88%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.